Biocon share price
You have to be logged in to add this to Watchlist.- ₹377.80(0.28%)March 17, 2026 15:57:16 PM IST
- NSE
- BSE
- Vol : 2.77 M (NSE + BSE)Last 20 day avg : 3.31 M
Biocon is trading 0.28% upper at Rs 377.80 as compared to its last closing price. Biocon has been trading in the price range of 382.80 & 375.20. Biocon has given -4.28% in this year & -3.25% in the last 5 days. Biocon has TTM P/E ratio 80.72 as compared to the sector P/E of -57.47.There are 14 analysts who have initiated coverage on Biocon. There are 5 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 143.80 Crores in its last quarter.Listed peers of Biocon include Torrent Pharmaceuticals (1.01%), Cipla (-1.34%), Sun Pharmaceutical Industries (0.46%).The Mutual Fund holding in Biocon was at 17.03% in 14 Jan 2026. The MF holding has increased from the last quarter. The FII holding in Biocon was at 7.14% in 14 Jan 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Mar 17, 2026, 03:24 PM UTC
- BetaMedium volatility0.87Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.85The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.13Annual dividends as a percentage of the stock price.
- P/EHigher than historical values77.74Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation4.86The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Neutral | 4,305.95 | 1.01 | 1,45,727.06 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Bearish | 1,281.45 | -1.34 | 1,03,513.05 | 22.95 | 3.87 | 0.87 | 0.81 |
| Sun Pharmaceutical Industries | Bullish | 1,790.70 | 0.46 | 4,30,738.26 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Neutral | 1,281.55 | 0.51 | 1,06,958.67 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | Bearish | 6,094.00 | 0.31 | 1,62,563.29 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-10-01 | Redemption (Part) of NCD |
| 2025-08-07 | Quarterly Results |
| 2025-05-08 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE376G01013
- BSE Code532523
- NSE CodeBIOCON
Biocon is trading at 377.80 as on Tue Mar 17 2026 10:27:16. This is 0.28% upper as compared to its previous closing price of 376.75.
The market capitalization of Biocon is 61490.88 Cr as on Tue Mar 17 2026 10:27:16.
The average broker rating on Biocon is Buy. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 4 analysts have given a buy rating
- 2 analysts have given a hold rating
- 3 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Biocon is 424.95 whereas the 52 wk low is 295.30
Biocon can be analyzed on the following key metrics -
- TTM P/E: 80.72
- Sector P/E: -57.47
- Dividend Yield: 0.13%
- D/E ratio: -
Biocon reported a net profit of 1013.30 Cr in 2025.
The Mutual Fund Shareholding was 17.03% at the end of 14 Jan 2026.